Examining features of melanocytic tumors in the central nervous system
Clinical, Radiological, Histological and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System
Central Hospital, Nancy, France · NCT05984108
This study is trying to better understand rare brain tumors that come from skin cells to help doctors tell them apart from other similar conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France (other) |
| Locations | 1 site (Nancy) |
| Trial ID | NCT05984108 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on primary melanocytic tumors of the central nervous system, which are rare and arise from leptomeningeal melanocytes. It aims to differentiate these tumors from other conditions, such as metastatic melanoma and malignant melanotic nerve sheath tumors, through comprehensive assessments including dermatological examinations and molecular characterizations. The study will analyze clinical, radiological, histological, and molecular features to improve diagnostic accuracy and understanding of these tumors.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with a primary meningeal melanocytic tumor.
Not a fit: Patients with metastatic extrameningeal melanoma will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the diagnostic process for patients with melanocytic tumors of the central nervous system, leading to more accurate treatment plans.
How similar studies have performed: While this study addresses a rare condition, similar approaches in characterizing tumors have shown promise in improving diagnostic accuracy in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with a primitive meningeal melanocytic tumor Exclusion Criteria: * Patient with metastatic extrameningeal melanoma
Where this trial is running
Nancy
- Nancy University Hospital Center — Nancy, France (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Meningeal Melanocytoma, Meningeal Melanomatosis, Meningeal Melanocytosis, Meningeal Melanoma